A Case of Diffuse Alveolar Hemorrhage Following Abciximab Therapy |
Ryu, Han Jun
(Department of Internal Medicine, Daegu Fatima Hospital)
Jung, Yeoun-Su (Department of Internal Medicine, Daegu Fatima Hospital) Kim, Min-Hee (Department of Internal Medicine, Daegu Fatima Hospital) Jung, Ho-Jin (Department of Internal Medicine, Daegu Fatima Hospital) Jung, Byung-Chun (Department of Internal Medicine, Daegu Fatima Hospital) Lee, Bong-Ryeol (Department of Internal Medicine, Daegu Fatima Hospital) Kang, Hyun-Jae (Department of Internal Medicine, Daegu Fatima Hospital) |
1 | Lara AR, Schwarz MI. Diffuse alveolar hemorrhage. Chest 2010;137:1164-1171. DOI ScienceOn |
2 | Nikolsky E, Mehran R, Dangas G, et al. Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approach. Eur Heart J 2007;28:1936-1945. DOI ScienceOn |
3 | Ener RA, Bruno N, Dadourian D, et al. Alveolar hemorrhage associated with platelet glycoprotein IIb/IIIa receptor inhibitors. J Invasive Cardiol 2006;18:254-261. |
4 | Platelet glycoprotein IIb/IIIa receptor blockade and lowdose heparin during percutaneous coronary revascularization: the EPILOG Investigators. N Engl J Med 1997;336: 1689-1696. DOI ScienceOn |
5 | Topol EJ, Califf RM, Weisman HF, et al. Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months: the EPIC Investigators. Lancet 1994;343: 881-886. DOI ScienceOn |
6 | Aguirre FV, Topol EJ, Ferguson JJ, et al. Bleeding complications with the chimeric antibody to platelet glycoprotein IIb/IIIa integrin in patients undergoing percutaneous coronary intervention: EPIC Investigators. Circulation 1995; 91:2882-2890. DOI ScienceOn |
7 | Sitges M, Villa FP. Massive pulmonary hemorrhage in a patient treated with a platelet glycoprotein IIb/IIIa inhibitor. Int J Cardiol 1997;62:269-271. DOI ScienceOn |
8 | Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE Study. Lancet 1997;349:1429-1435. DOI ScienceOn |
9 | Ali A, Hashem M, Rosman HS, Kazmouz G, Gardin JM, Schrieber TL. Use of platelet glycoprotein IIb/IIIa inhibitors and spontaneous pulmonary hemorrhage. J Invasive Cardiol 2003;15:186-188. |
10 | EPISTENT Investigators. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. Lancet 1998;352:87-92. DOI ScienceOn |